686 EFFECTS ON PRURITUS AND SLEEP DISTURBANCE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) AFTER 1 YEAR OF TREATMENT WITH SELADELPAR, A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA AGONIST: RESULTS OF AN OPEN-LABEL PHASE 2 STUDY
Andreas E Kremer, Marlyn J Mayo, Christopher L Bowlus, Guy Neff, Mark G Swain, Michael Galambos, Aparna Goel, Palak Trivedi, Gideon Hirschfield, Richard Aspinall, …
Gastroenterology (New York, N.Y. 1943), Vol.158(6), pp.S-1284-S-1285
686 EFFECTS ON PRURITUS AND SLEEP DISTURBANCE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) AFTER 1 YEAR OF TREATMENT WITH SELADELPAR, A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA AGONIST: RESULTS OF AN OPEN-LABEL PHASE 2 STUDY
Creators
Andreas E Kremer
Marlyn J Mayo
Christopher L Bowlus
Guy Neff
Mark G Swain
Michael Galambos
Aparna Goel
Palak Trivedi
Gideon Hirschfield
Richard Aspinall
Stuart C Gordon
Brian B Borg
Stephen Harrison
Paul Thuluvath
David E Jones
Yvonne Doerffel
Cynthia Levy
Carmen Stanca
David Sheridan
John M Vierling
Mitchell L Shiffman
Joseph Odin
Bruce Bacon
Tarek Hassanein
Douglas Thorburn
Christoph Berg
David Bernstein
Aliya Gulamhusein
Charles Landis
Adam Peyton
Lynsey Corless
Peter Buggisch
Marcus-Alexander Wörns
Sandrin Bergheanu
Monika Varga
Yu Li
Ke Yang
Klara Dickinson
Pol Boudes
Charles A McWherter
Alexandra Steinberg
Yun-Jung Choi
Publication Details
Gastroenterology (New York, N.Y. 1943), Vol.158(6), pp.S-1284-S-1285
Academic Unit
Miller School of Medicine; UMMG Dept of Medicine - Hepatology